Immunostaining of IBA1, a hallmark of microglial activation, in AD mouse brain sections revealed two evident stages of microglial activation, at the 3rd month and the 7–9th months, respectively (Fig. 1f; Supplementary information, Fig. S1h). This evidence concerns the gene AIF1 and Alzheimer disease.